1. Home
  2. Janus kinase 2
  Subject:

Janus kinase 2   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Myeloproliferative neoplasm  9 times
Myelofibrosis  8 times
Splenomegaly  3 times
Allele  3 times
Thrombosis  2 times
Thrombocytopenia  2 times
Placebo  2 times
Mutation  2 times
Janus kinase  2 times
Interferon  2 times
Fibrosis  2 times
Enzyme inhibitor  2 times
DNA sequencing  2 times
Bone marrow  2 times
Anemia  2 times
Umbilical vein  1 time
Telomerase  1 time
Syndrome  1 time
Sepsis  1 time
Sanger sequencing  1 time
Pneumonia  1 time
Platelet  1 time
Philadelphia  1 time
Phenotype  1 time
P53  1 time
Myeloid tissue  1 time
Leukocytosis  1 time
Kinase  1 time
Karyotype  1 time
Janus  1 time
India  1 time
IDH1  1 time
Hematology  1 time
Haematopoiesis  1 time
Growth factor  1 time
Gene  1 time
Flow cytometry  1 time
Finnish language  1 time
Exome  1 time
EZH2  1 time
Diarrhea  1 time
Cytokine  1 time
Collagen  1 time
ClinicalTrials.gov  1 time
Chronic myelogenous leukemia  1 time
Cell surface receptor  1 time
Capillary  1 time
Canada  1 time
CD34  1 time
B-cell chronic lymphocytic leukemia  1 time
Australia  1 time
Aspirin  1 time
Angiogenesis  1 time
Acute myeloid leukemia  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Endothelial tip cell formation induced by chronic lymphocytic leukemia plasma (JAK2 positivity amplified this effect)

2. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature

3. Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

4. Can pegylated interferon improve the outcome of polycythemia vera patients?

5. BCR-ABL and JAK2V617F Mutation Co-existence, Rare or Just Unexplored

6. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory

7. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

8. Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender

9. Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera

10. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

11. Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms

12. Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis

13. Pharmacotherapy of Myelofibrosis


Questions?

Drop us a message.